Skip to content

Community-based Prevention of Diabetes (ComPoD) trial

Community-based Prevention of Diabetes (ComPoD): a randomised trial with a waiting list control group to evaluate the effectiveness and cost-effectiveness of a third sector led, community-based diabetes prevention programme

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70221670
Enrollment
312
Registered
2014-09-05
Start date
2014-11-01
Completion date
Unknown
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Diabetes, Primary Care

Interventions

Living Well, Taking Control: The Living Well, Taking Control programme is an existing community-based diabetes prevention programme adherent with NICE guidance that is being provided by voluntary sect

Sponsors

University of Exeter (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: As per existing programme eligibility criteria we will recruit people who: 1. Are aged 18-74 years. 2. Are considered on the basis of recent blood glucose tests to be at high risk for type 2 diabetes according to the criteria in the recent NICE diabetes prevention guidance (fasting plasma glucose level 6.1- 6.9 mmol/L, or HBA1c 42-47 mmol/l recorded at any point within the last year). A check for progression to diabetes amongst trial participants will be made at baseline using point-of-testing HbA1c assessment equipment. 3. Are resident in Exeter and Tiverton (postcodes EX1-6; EX 16) or Birmingham (postcodes B1-21). 4. Have a BMI of at least 25 (23 for certain ethnic minority populations e.g. South Asians) and less than 45 kg/m2

Exclusion criteria

Exclusion criteria: 1. We will exclude people who have a terminal illness or do not have the mental capacity to give informed consent and understand study procedures with assistance from the researcher, an interpreter or other representative as necessary (e.g., due to dementia, severe learning disability) 2. Participants who have an HbA1c reading recorded at their baseline assessment indicating progression to Type 2 diabetes will also be excluded from the trial but will still be able to access the diabetes management component of the Living Well, Taking Control programme and will be referred accordingly There are no other exclusion criteria as the programme providers cater for people with low literacy, needing translation services or with mental health problems, learning or physical disabilities, and will support consenting and collecting data from these groups.

Design outcomes

Primary

MeasureTime frame
Weight loss (kg); Timepoint(s): Baseline, 6 months, 12 months

Secondary

MeasureTime frame
1. 7-day objectively measured physical activity (i.e., accelerometry); Timepoint(s): Baseline, 6 months, 12 months 2. Blood pressure; Timepoint(s): Baseline, 6 months, 12 months 3. Dietary change (fat and fibre); Timepoint(s): Baseline, 6 months, 12 months 4. HbA1c (indicating average blood sugar levels over 3 months); Timepoint(s): Baseline, 6 months, 12 months 5. Mental health and well-being; Timepoint(s): Baseline, 6 months, 12 months 6. Other anthropometric measures (e.g., waist circumference, % body fat, muscle mass); Timepoint(s): Baseline, 6 months, 12 months 7. Perceived importance of and confidence in achieving healthy levels of activity and a healthy diet; Timepoint(s): Baseline, 6 months, 12 months 8. Quality of life (EuroQoL EQ5D); Timepoint(s): Baseline, 6 months, 12 months 9. Self-reported physical activity (NZPAQ); Timepoint(s): Baseline, 6 months, 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 1, 2026